Nuclear families with multiple affected sibs are often collected for genetic linkage analysis of complex diseases. Once linkage evidence is established, dense markers are often typed in the linked region for genetic association analysis based on linkage disequilibrium (LD). Detection of association in the presence of linkage localizes disease genes more accurately than the methods that rely on linkage alone. However, test of association due to LD in the linked region needs to account for dependency of the allele transmissions to different sibs within a family. In this paper, we define a joint model for genetic linkage and association and derive the corresponding joint survival function of age of onset for the sibs within a sibship. The joint survival function is a function of both the inheritance vector and the genotypes at the candidate marker locus. Based on this joint survival function, we derive score tests for genetic association. The proposed methods utilize the phenotype data of all the sibs and have the advantages of family-based designs which can avoid the potential spurious association caused by population admixture. In addition, the methods can account for variable age of onset or age at censoring and possible covariate effects, and therefore provide important tools for modelling disease heterogeneity. Simulation studies and application to the data sets from the 12th Genetic Analysis Workshop indicate that the proposed methods have correct type 1 error rates and increased power over other existing methods for testing allelic association.
INTRODUCTION
Information on the age of a patient at disease onset, an important feature of complex disease such as breast cancer (Claus et al., 1990) , prostate cancer (Carter et al., 1992) and Bipolar (Stine et al., 1995) , is often collected in studies designed to map the disease genes. If age at onset is genetically mediated, subjects' age at onset can carry useful information. Studies of these complex diseases show a significant age of onset correlation between family members. Furthermore, early age of onset of breast cancer, type 1 diabetes and Alzheimer's disease has been associated with an increased risk in relatives (Claus et al., 1990; Caillat-Zucman et al., 1992; Meyer et al., 1998) . In addition, many complex diseases are due to multiple disease genes and environmental risk factors and/or interactions among these factors. Genetic analysis that allows for the simultaneous consideration of susceptibility from multiple regions, environmental risk factors and variable age of onset may improve the ability to map genes for complex diseases (Schork et al., 1993; Knapp et al., 1994; Buhler et al., 1997; Cox et al., 1999; Li and Huang, 1998; Li, 1999; Li and Hsu, 2000; Li and Zhong, 2002; Li, 2002) .
Linkage analysis has been successful in the localization of genes for many monogenic human diseases exhibiting Mendelian inheritance. But for complex diseases, tests for association have been proved to be more powerful (Risch and Merikangas, 1996) . The presence of allelic association caused by linkage disequilibrium (LD) is sometimes used to localize a disease gene more accurately, the idea being that the disease gene is often closest to that marker showing the highest degree of allelic association with it. On the other hand, LD tends to exist only over very short regions so that strong disequilibrium generally indicates very short distance. Allelic association tests through traditional contingency table analysis using cases and controls are sensitive to spurious association caused by population admixture. Therefore alternative methods using family-based designs to obviate the effects of population heterogeneity/admixture have become increasingly popular. Those methods include the transmission/disequilibriom test (TDT) (Spielman et al., 1993; Ewen and Spielman, 1995) , the haplotype-relative risk approach (Terwilliger and Ott, 1992 ) and the likelihood-based approaches (Schaid, 1996; Schaid and Li, 1997; Whittemore and Tu, 2000; . Shih and Whittemore (2002) proposed nonfounder score test statistic to extend the TDT to accommodate multiple affected and unaffected children and age at disease onset or censoring survival data. However, all these methods or tests were developed for testing genetic linkage using association methods or for testing the composite null hypothesis of no linkage or no association, i.e. H 0 : θ = 1/2 or δ = 0, where θ is the recombination parameter and δ is a measure of allelic association or LD.
Detection of association in the presence of linkage localizes disease genes more accurately than those methods that rely on linkage alone (Lake et al., 2000; Fulker et al., 1999) . In this case, the null hypothesis of testing association in the presence of linkage is H 0 : δ = 0 and θ < 1/2. It is well known that the transmissions of alleles to different sibs within a family are dependent in the linked region (Ewen and Spielman, 1995; Rabinowitz, 2002) . Therefore, direct applications of some of the tests such as TDT treating sibs within a family as independent will result in inflated type 1 error rates when such tests are used for testing genetic association. Several attempts to account for such dependence when testing for genetic association have been made in the literature. The TDT was extended to allow independent nuclear families with multiple affected children while remaining a valid test of association (Martin et al., 1997) . Lake et al. (2000) proposed family-based tests of association which use a robust empirical variance-covariance estimation to take into account the correlation among sibling marker genotypes in the presence of linkage. However, none of these tests explicitly accounts for the gene identity by descent (IBD) sharing among the sibs in the linked region.
In order to account for variable age of onset and different allele-sharing patterns in genetic association test, we propose in this paper to develop a joint model for both linkage and association due to LD, where the linkage part is modelled by the additive genetic frailties as in Li and Zhong (2002) and the association part is modelled as a covariate. Based on this model, we derive a score test of the null hypothesis of no linkage disequilibrium accounting for within-family correlation of age of onset due to linkage. The test derived is a weighted score test and is a valid test for association in the presence of linkage when multiple sibs from the same families are used. The test is also valid in the presence of population admixture or population substructure.
The rest of the paper is organized as follows. We first introduce the additive genetic gamma frailty model which simultaneously considers both linkage and association due to LD. We then define a conditional retrospective likelihood function for sibship age of onset data and derive a score test for association in the presence of linkage. We present simulation studies to assess the properties of the proposed test and apply the methods to the data sets from the 12th Genetic Analysis Workshop (GAW12) to further demonstrate the practical applicability of the proposed methods. Finally, the results of the paper and concluding remarks are given in the Discussion section.
A MODEL FOR JOINTLY MODELLING LINKAGE AND ASSOCIATION DUE TO LINKAGE

DISEQUILIBRIUM
It is well known that genetic linkage induces within family association of the phenotypes such as disease onset or age at disease onset. The allele-sharing-based linkage analysis only considers allele sharing by descent pattern among the sibs within a sibship. However, it does not differentiate which allele they share as long as they share it by descent. In other words, linkage analysis does not consider which particular allele is shared by the sibs. On the other hand, the association that we are interested in is the association due to LD. For association analysis and LD analysis, the particular allele which an individual carries determines his/her risk of developing disease, since different marker alleles have different coupling frequencies with the disease variant if LD exists. In a typical test of association, it is very rare that the genetic marker itself is the disease susceptible locus (DSL). When the marker locus is not the DSL but is in LD with it, all sibling resemblance or lack of resemblance and within sibship correlation of age of onset cannot be fully accounted for by the genotypes at the marker locus. Motivated by this key difference between linkage and LD, we define in the following a joint model for the risk of disease to account for both the allele sharing information and the genotype information at the candidate marker locus by including the genetic frailties derived from the inheritance vector.
Consider a sibship with n sibs. Let T j be the random variable of age at disease onset for the jth sib. Let (t j , δ j ) be the observed data where t j is the observed age at onset if δ j = 1, and age at censoring if δ j = 0. Consider a candidate marker d in the linked region and let g = (g 1 , . . . , g n ) denote the vector of genotypes at marker locus d of the n sibs of known age at onset or censoring. We assume that the hazard function of developing disease for the jth individual at age t j is modelled by the proportional hazards model with random effect Z j ,
where λ 0 (t) is the unspecified baseline hazard function and X g j denotes some function of the jth offspring's marker genotype in the family: for example, for additive model, X g j = l, l = 0, 1, 2, counts the number of the putative high-risk marker allele and is for the genotype of jth member in the family who carries l copies of the putative high-risk marker allele. Z j is the unobserved genetic frailty. Following Li and Zhong (2002) , we define the genetic frailty as . . . , v 2n−1 , v 2n ) are the inheritance vectors (Kruglyak et al., 1996; Lander and Green, 1987) of sibship at the d locus, v 2 j−1 = 1 or 2, and v 2 j = 3 or 4 for j = 1, 2, . . . , n. The inheritance vector indicates which parts of the genome at locus d are transmitted to the n children from the father and the mother. Here U d1 and U d2 are used to represent the genetic frailties due to part of the genome on the two chromosomes of the father at locus d. U d3 , and U d4 are analogous though for the mother. 
The parameter ν d /η 2 can be interpreted as the proportion of the variance of the genetic frailty which can be explained by the locus d.
Assuming conditional independence, we can see that conditioning on the frailty vector Z = {Z 1 , . . . , Z n }, the joint survival function for a sibship age of onset can be written as
where j (t j ) = 0 (t j ) exp(X g j β), j = 1, 2, . . . , n, and 0 (t) = t 0 λ 0 (s) ds is the cumulative baseline hazard function. Li and Zhong (2002) derived the unconditional joint survival function by integrating out Z 1 , Z 2 , . . . , Z n , which can be written as 2, . . . , n, and I (.) is the indicator function. It is important to note that this joint survival function for the sibship age of onset data depends on both allele-sharing information and the marker genotype information. Even in the absence of allelic association (i.e. when β = 0), the ages at the disease onset of the sibs within a sibship are still correlated due to genetic linkage in the test region. By taking respective derivatives of the joint survival function (2.2), we can get the joint survival and density function Pr(t 1 , δ 1 , . . . , t n , δ n ) which is shown as equation (A.1) in the Appendix.
A SCORE TEST FOR GENETIC ASSOCIATION IN THE PRESENCE OF LINKAGE
A conditional retrospective likelihood function
When β = 0, the hazard function (2.1) and the joint survival function (2.2) for a sibship do not depend on the genotype at the marker locus d. Therefore, test of allelic association between locus d and the disease or the null hypothesis that genotype at marker locus is not associated with the risk of the disease can be formulated as testing
Consider N nuclear families with n i children in the ith family,
. . , g in i ) be the vector of the marker genotypes at the candidate marker locus for the n i children in the ith family, and g i = (g i F , g i M ) be the vector of parental marker genotypes. Let V d be the inheritance vector at the marker locus d.
be the observed age at onset or censoring data for the n i children where t i j is age at onset if δ i j = 1 and age at censoring if δ i j = 0, and δ i j is disease status indicator, for j = 1, . . . , n i . For a given inheritance vector v d , we formulate the likelihood contribution of the ith family as the conditional probability of the children's marker genotype data, conditioning on children's age at onset or censoring data (offspring phenotypes) and the parental marker genotypes. This retrospective formulation of the likelihood as the probability of genotypes conditioning on the phenotypes effectively avoids direct consideration of the ascertainment issue (Whittemore, 1996; Li and Zhong, 2002) . The likelihood for the ith sibship can be written as
where M denotes summation over all possible offspring genotype vector M. We assume that an individual's phenotype does not depend on relatives' genotypes given his or her own genotype. In this
is the marginal probability of the offspring phenotypes. Note that Pr(t i , δ i |M i ) is a function of both the inheritance vector v d and the sibs' genotypes (see equation (A.1) in the Appendix). We assume that 0 (t) is known or can be estimated by external data and denote the log likelihood for the family as
Note that by conditioning on parental genotypes, we perform test within the family, and therefore it is not subject to possible bias due to population admixture.
A score test for genetic association
We now derive the efficient score test for H 0 : β = 0 based on the conditional likelihood function (3.1). Here the parameters related to the linkage part of the model, ν = (ν d , ν p ) , are the nuisance parameters. The log likelihood for the ith family can be written as
∂β | β=0 denote the first derivative of the log likelihood over β taken at β = 0, and
) denote the first derivative of the log likelihood over ν taken at β = 0. A natural efficient score for the ith family is then defined as
where I βν and I νν are elements of the information matrix. As shown in equation (A.3) in the Appendix,
= 0, therefore the efficient score has the simple form
which is the same as the score when ν is known. Its asymptotic variance is
which is the information for parameter β evaluated at β = 0. This can be estimated by the observed information
Based on the log likelihood function (3.1), we can derive the score as
where
and details of derivation of this score are given in the Appendix. The score is thus a weighted sum over all children of the deviation between observed genotype score and the expected genotype score conditioning on the parents' genotypes, where the weights are functions of age of onset/censoring and the inheritance vector at the marker locus.
For N independent sibships, summation of the score for each family over all the N families gives the total efficient score statistic S(ν) = N i=1 S i (ν). Letν be the maximum retrospective likelihood estimator of ν under the null hypothesis, H 0 : β = 0 (see Li and Zhong, 2002 for the definition of the retrospective
is asymptotically normally distributed with mean 0 and variance 1 under the null hypothesis of no linkage disequilibrium (Cox and Hinkley, 1974) . The statistical significance for association can be estimated by comparing the observed T to a standard normal distribution, or equivalently,
is asymptotically chi-square distributed with one degree of freedom.
It is interesting now to relate the new score test to other proposed tests in the literature. First, when the F i function is omitted from the score statistic (3.2), the score statistic is the same as the non-founder score statistic proposed by Shih and Whittemore (2002) , where the weight is defined as the difference between the disease status indicator and the baseline cumulative hazard function. However, the non-founder score test is a test for linkage that uses association method, and thus may not be valid for testing association in the presence of linkage. Second, our score statistic is a weighted sum of
} over all sibs. An unweighted score for the ith family with m i affected sibs (assuming that the first m i sibs are affected) and n i − m i unaffected sibs can be defined as
and its variance is V ui = E(S 2 ui ) and could be estimated by S 2 ui . An unweighted score test statistic can be defined as
It is easy to verify that this unweighted score test is the standard TDT for family trios data where each family has only one single affected child. The unweighted score statistic is also identical to the T sp test statistic proposed by Martin et al. (1997) for families with two affected sibs when the parental genotypes are known. When empirical variance-covariance estimator for the score is used, these unweighted score tests give valid test of association in the presence of linkage (Lake et al., 2000) .
For simplicity of presentation, the weighted score statistic we defined is derived under two assumptions. First, we assume that the inheritance vector V d at the test locus is known. In practice, V d is often not known precisely. However, we can estimate the probability distribution function by using Lander and Green's algorithm (Lander and Green, 1987) and then average the scores over the probability distribution of the inheritance vectors. Second, we assume that the parental genotypes are known. If there are missing parental genotypes, we can replace E(X g i j |g i F , g i M ) in our definition of the score with
is the minimal sufficient statistic for the parental genotypes as defined by Rabinowitz and Laird (2000) and Lake et al. (2000) . The algorithm in Rabinowitz and Laird (2000) can be used for calculating the expectations.
Scores for some special cases
To get some ideas on how different parameters affect the weights in our proposed weighted score test, we present in Table 1 the closed forms of the scores for some special cases assuming that ν p = 0 and ν d is known, including the scores for the affected individual, affected sib pairs (ASPs) and discordant (one affected and one unaffected) sib pairs (DSPs). Note that when the two sibs share zero allele IBD, the 
weights depend only on their own age at disease onset, but when they share one or two alleles IBD, the weights are a function of the age of onset of both sibs.
To demonstrate how the weight function depends on the IBD sharing, genetic effects and age of onset, we present here several examples. We assume a Weibull baseline hazard function 0 (t) = (t/b) τ , with b = 80 and τ = 5 and consider models with ν p = 0, and ν d = 0.8 or ν d = 0.3, where the model with ν d = 0.3 corresponds to stronger within sibship correlation due to genetic effects. Figure 1(a) shows the corresponding population disease-free survival curves together with the survival curve corresponding to the baseline hazard. Model with ν d = 0.3 corresponds to stronger genetic effect than the model with ν d = 0.8. Figure 2 shows the weight functions for affected sibs with different age of onset. In general, sibs with early age of onset are given greater weight than late-onset sibs in the analysis. If a sib pair shares zero allele IBD, then the weight for the first sib is a decreasing function of her/his own age of onset, but it does not depend on age of onset of the other sib. However, when an ASP shares one or two alleles IBD, the weight function of one sib is a function of age at disease onset of both sibs, especially for sib pairs who share two alleles IBD. For a sib pair who shares two alleles IBD, the weights can be negative. For a sib with early age of onset, the weight is an increasing function of the age of onset of the second sib. However, for a sib with late age of onset, the absolute value of the weight is a decreasing function of the age of onset of the second sib. The actual cutoff values of differentiating early from late onset depend on the underlying genetic models.
SIMULATION STUDIES
This section presents the results of simulation studies to evaluate the proposed tests. For the simulation studies, we generated age of onset data from several different genetic models and generated the current age of each individual from a uniform distribution U(60, 80). An individual with a simulated age of onset earlier than his/her simulated current age is defined as affected while an individual with a simulated age of onset later than his/her simulated current age is defined as censored at the current age. For all the simulations, markers with four alleles A 1 , A 2 , A 3 and A 4 of equal frequencies were simulated based on two different sets of LD coupling frequencies between the two disease locus alleles and four marker alleles (see Table 2 ). The parental mating type of each family is set to be A 1 A 2 by A 3 A 4 . It is clear to see that marker allele A 1 is in linkage disequilibrium with the disease allele and is positively associated with the disease. So A 1 is of particular interest and we are interested in the behavior of our proposed tests on association between A 1 and disease when there is linkage. To evaluate the type 1 error rates of the proposed score test for genetic association in the presence of linkage, we consider two different models for simulating genetic linkage effect. The first type of null model assumes that the genetic linkage effect is modelled by the additive genetic gamma frailty model (2.1) but with β = 0. We considered ν d = η = 0.8 or ν d = η = 0.3. Genetic markers are generated by assuming no recombination between the disease gene and the markers. The corresponding baseline survival curve S 0 (t) = exp[− 0 (t)], together with the corresponding population disease-free survival (S p (t) = exp[− p (t)]) curves, are shown in Figure 1(a) . The second type of null model assumes that there is linkage between the disease and the marker by simulating age of onset data from a Weibull hazard 
where X g is the numerical code for genotype g at the disease locus and g takes one out of three possible values D D, Dd and dd, where D is the high risk disease allele. The markers are generated based on Mendelian segregation under the assumption of no linkage disequilibrium with the disease locus by assuming equal coupling frequencies (see Table 2 , null model). Genetic relative risk parameter β = log(2) or β = log(3) was used for generating the data. The baseline survival curve and the survival curves for different β are shown in Figure 1(b) . For each model, we considered two different sampling schemes: collecting only ASPs and collecting DSPs. For each scheme, the first 100 or 200 sib pairs who met the sampling criteria are collected. For each model, several different tests were performed, including the proposed weighted score test, the unweighted score test and the TDT. For all the tests, the marker alleles A 2 , A 3 and A 4 were grouped as one allele and allele A 1 is tested for possible association with the disease. The estimated type 1 error rates based on 5000 simulations for various models and tests are presented in Table 3 . For both weighted and unweighted score tests, the empirical type 1 error rates are close to pre-specified significance level for both types of null models, indicating those tests have correct type 1 error rates. For the ASPs, the standard TDT test has inflated type 1 error rates for testing association when treating each ASP as two independent trios. In such case, the TDT is valid when only one affected sib was used. However, as shown in the next section, this results in decrease in power in detecting the LD.
Simulation-comparisons of the power
To evaluate the power of the proposed test, we performed several sets of simulations under different genetic models. For each model, we first simulated the marker genotypes by assuming four equally frequent alleles and then simulated the disease genotypes based on the coupling frequencies given in Table 2 . We then simulated the age of onset data based on model (4.1). Two different genetic relative risk ratio parameters of 2 and 3 were considered. We considered both the scenarios of collecting ASPs and DSPs.
We first simulated a common disease with high lifetime cumulative disease incidence by choosing b = 80, τ = 5 in the Weibull baseline hazard function in model (4.1). We considered two different sets of coupling frequencies (shown as Model 1 and Model 2 in Table 2 ). The disease allele frequency and the LD measure are 0.25 and 0.03 for Model 1 and 0.05 and 0.006 for Model 2. Figure 1(b) shows the disease-free survival functions for the baseline and for individuals who carry one high risk allele. This model simulates a high baseline risk of developing disease and therefore high frequency of sporadic cases in the population. Table 4 presents the results of power comparisons based on 500 replications for various sample sizes and ascertainment schemes. The conclusions can be summarized as the following: first, the weighted score test clearly resulted in much higher power than the unweighted score test; second, for diseases with the high cumulative incidence as we simulated, collecting DSPs can result in much higher power than collecting ASPs only; third, for the DSP case, our proposed weighted score test gave much greater power than the standard TDT test which uses only affected sibs and certainly loses much information. Finally, as expected, the power of detecting genetic association is very low when the true LD is weak, e.g. for coupling Model 2.
We next simulated a disease with moderate baseline risk by assuming the population hazard function as λ p (t) = αc p d e (t − 40) r + , with α = 3.7 × 10 −7 , r = 2.654, c p = 2.87, d e = 1.00. This hazard function approximates the observed disease rate of prostate cancer in the population based on the SEER database. We considered three different risk ratio parameters β = log(2), β = log(3) and β = log(10). Again two different LD patterns as shown in Table 2 were considered. Figure 1(c) shows the disease-free survival functions for the baseline and for individuals carrying one high risk allele. This model simulates a moderate baseline risk of developing disease.
The second part of Table 4 presents the results of power comparisons based on 500 replications for various sample sizes and ascertainment schemes for both LD models. First, we notice that when the genotypic relative risk is modest, the differences in power between the weighted and unweighted score tests are very small for both ASPs and DSPs. However, when the genotypic relative risk ratio is large such as 10, we still observe certain increase in power by using the weighted score test. Second, for diseases with the moderate lifetime cumulative incidence as we simulated, collecting ASPs results in higher power than collecting DSPs in detecting genetic association. This is in contrast to diseases with very high cumulative incidence, in which case collecting DSPs results in higher power. Finally, for all the models considered, the TDT using only one affected sib always resulted in lower power than our proposed tests.
Simulations-effects of misspecification of the baseline hazard function
The simulations conducted above assume correct specification of the baseline hazard function. Since the baseline hazard function appears only in the weight of the score test, the test still has correct type 1 error rate when it is misspecified. However, misspecification of the baseline hazard function may affect the power of the score test. We performed a small simulation study to examine the impact of misspecification (2) EWST 0 of baseline hazard function on the power of the proposed weighted score test. In simulating the data, we used a Weibull baseline hazard function as in equation (2.1) with parameters b = 80 and τ = 5. In addition, we simulated gamma frailties with ν d = η = 0.8 and a marker genetic relative risk of log(3) in the proposed joint model (2.1). Figure 3 presents the power of the score test for different specifications of the baseline hazard function by assuming a range of values for b and τ in the baseline hazard function. We can see that the power of the weighted score test is relatively robust to the misspecification of the baseline hazard function unless it is greatly misspecified. In summary, the simulation studies indicate that the proposed tests have correct type 1 error rates and good power for both ASPs data and DSPs data. In addition, the power of the proposed test is relatively robust to misspecification of the baseline hazard function used in the model. 
APPLICATION TO GAW12 SIMULATED DATA SETS
We applied our proposed test to the GAW12 simulated data of general population (Almasy et al., 2001) . In generating the disease data, seven major genes were simulated to influence the disease liability and age of onset, out of which the major gene 7 directly contributes to age of onset and major gene 6 directly contributes to disease liability. Both major genes 6 and 7 reside on chromosome 6, with major gene 6 on the 30.5cM position and major gene 7 on the 31.5cM position. Details on how the data were generated can be found in Almasy et al. (2001) . Although the genome-wide marker data are available, to demonstrate our proposed methods, we focus our analysis on chromosome 6, which includes a total of 152 microsatellite markers spaced at an average of about 1 cM apart.
The GAW12 general population data include a total of 50 replicates, each containing 23 extended pedigrees with a total of 1497 individuals. Since our proposed methods only apply to sibship data, we first sampled 500 independent affected sib pairs with their parents from the first 30 replicates of simulated data sets. In order to obtain an estimate of the baseline hazard of the disease, we calculated the KaplanMeier nonparametric survival estimate using the age of onset data or age at last followup data from all the founders of the first 30 replicates. The Kaplan-Meier survival curves for females and males are shown in Figure 4 (a), indicating differences in disease rates between males and females.
We first applied the retrospective likelihood ratio test proposed in Li and Zhong (2002) to perform multipoint linkage analysis for chromosome 6. Figures 4(c) and (d) present the LOD score plot for chromosome 6 region without and with adjusting for sex as a covariate. The tests show strong evidence of linkage at the location where the major genes reside and the evidence is stronger after adjusting sex as a covariate (see Figure 4(d) ). In addition, little evidence of linkage at the locations far away from where the majors genes reside was observed. As a comparison, Figure 4(b) shows the results of linkage analysis using the mean IBD test. Although a peak in the mean IBD statistic was observed around the disease genes, no strong evidence of linkage can be concluded from the mean IBD test. These results clearly demonstrate the importance of adjusting for age of onset and covariate data in genetic linkage analysis.
We then applied our proposed score test for genetic association analysis for 98 single nucleotide polymorphisms (SNPs) in the coding region of major gene 6. Figure 5 plots the negative logarithms of the p-values of four different test statistics versus the sequence number of the 98 SNPs. When no covariate adjustment is included in the model, we see that the weighted score test and unweighted score test perform similarly across all the 98 SNPs, both showing some evidence of association at some SNP markers at the 0.01 level (see plots (a) and (c)). However, when the conservative Bonferroni adjustment was applied, none of these SNPs showed any strong association with the disease. When we adjusted sex as a covariate in our model, the results (see Figure 5 (b)) showed that five SNPs in the promotion region of gene 6 are significantly associated with the disease. This analysis demonstrated the importance of adjusting for covariate effect in genetic association analysis. Finally, as a comparison, Figure 5(d) shows the test results of the TDT using only one affected sib from each family, indicating great loss of power by using only one affected sib in the TDT. 
DISCUSSION
Genetic association due to linkage disequilibrium provides potentially powerful tool for locating the disease genes for complex diseases. When multiple sibs from a sibship are used for association test in the linked region, it is important to account for the dependencey of allele transmissions to different sibs in the region. We have introduced a joint model for the risk of disease, accounting for both linkage and LD information. Based on this joint model, we have derived a joint survival function for age of onset for the sibs within a sibship and proposed an efficient score test for genetic association. Explicitly accounting for IBD sharing information and therefore the dependency of transmissions to different sibs in the test of association ensures that the score test has correct type 1 error rate. This joint model should increase the power of detecting a DSL when the marker locus is not the DSL but is in LD with the DSL and when age of disease onset is mediated by genetic factors. Our test statistic has similar form as some of the previously proposed methods, but has different weight functions. The proposed test can simultaneously incorporate both age at ascertainment or age at onset information and additional covariates such as genotypes at unlinked marker loci by including the covariates in the joint model (2.1). When testing for the genetic association, the regression coefficients for the additional covariates can be treated as nuisance parameters along with the linkage parameters. As demonstrated by the simulation studies, the proposed methods can greatly increase the power of mapping genes by association analysis over some existing association tests, especially for diseases with high lifetime cumulative incidence or modestly common diseases with large genetic relative risks. Our simulation results also demonstrate that when the cumulative disease incidence rate is high in the study population, collecting discordant pairs can potentially increase the power of detecting genetic association as compared to collecting only affected sib pairs.
The methods presented in this paper are related to some previously developed methods in taking into account IBD sharing when testing for genetic association. Lake et al. (2000) discuss the calculation of the mean and variance of the score similar to ours when testing the null hypothesis of H 0 : δ = 0 and θ < 1/2. However, they realized substantial loss of efficiency when there are missing parental data or when the IBD sharing is not certain and instead proposed to use empirical variance-covariance estimate of the score variance in defining the score statistics. When considering dichotomous traits, their score statistic is the same as our unweighted score statistics T u . One advantage of our approach is that even when the allele-sharing pattern is uncertain for the sibs within a sibship, we can still use such sibships by considering the probability distribution of the inheritance vector. Fulker et al. (1999) and Abecasis et al. (2000) proposed combined linkage and association analysis for quantitative traits using sib pairs and nuclear family data, where the main genetic effect is modelled as the mean and the IBD sharing is modelled in the variance-covariance matrix in the variance components model. The method proposed in this paper is similar in spirit to these variance-components models. Within this joint modelling framework, one can also test for linkage while simultaneously modelling association, which in turn provides a test of whether the putative disease locus is a candidate or whether it is merely in disequilibrium with a trait locus. If significant linkage is detected while modelling for association, one can conclude that the putative locus is not the functional gene but, rather, is a locus in disequilibrium with a trait locus. It is an interesting future research topic to study this possibility in detail.
As pointed out by one of the reviewers, for those special cases listed in Table 1 ,
in the weight function is precisely the posterior expectation of the random effects Z i j and the weights are simply log-rank scores which incorporate empirical Bayes' estimates of the random effects. In this case, the score statistic can be expressed as an inner product of 'observed minus expected' score for phenotypes and transmissions. However, for more general sibships, we are not able to formally prove this statement due to the complexity of the weight function.
Our proposed models and tests depend on several assumptions. First, we make the proportional hazards assumption on the random frailty effects and the marker genotype effect, which may be violated for some complex diseases when the genetic effects are stronger at older age than at younger age. While it is possible to develop robust inference procedure for β under misspecified proportional hazards models along the lines of Lin and Wei (1989) , it is not clear how to make the random effects time-dependent. An alternative approach is to formulate the problem as accelerated failure time models. Second, we assume that the genetic effects within locus are additive. The within locus additivity has been shown to work well with respect to test power for a wide range of disease models for both linkage analysis (e.g. Tang and Siegmund, 2001 ) and association analysis (e.g. Schaid, 1996) . When the mode of inheritance is unknown, we expect that this assumption would result in relatively robust power when compared with dominant, recessive or multiplicative assumptions. Third, the proposed model assumes gamma distributions for the random effects for both mathematical and computational convenience. It is possible to assume other distributions such as the log-normal or the positive-stable distribution, although the computation would not be as simple. It is however important to note that, even some of the assumptions listed above are violated, the proposed score test should still have correct type 1 error rate, since these assumptions only affect the weights in the score statistic and under the null hypothesis of no association, the expected value of the score is still zero. An important future research is to study how robust the power is to the misspecification of these assumptions and to devise statistical procedures for testing these assumptions.
As dense maps of SNPs are now available and costs of genotyping by high-throughput methods decline, the dissection of linked region may be accomplished by saturating the linked regions with SNPs and performing association tests on them. The methods presented in this paper should provide useful tools for association mapping of complex diseases, especially for those diseases with phenotype heterogeneity such as variable age of onset and/or with etiology heterogeneity such as those caused by both genetic and environmental risk factors. Lander and Green, 1987; Kruglyak et al., 1996) 
